First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study

@article{Marchetti2011FirstlineMC,
  title={First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study},
  author={Veronica Marchetti and Mario Giorgi and Anna Fioravanti and Riccardo Finotello and Simonetta Citi and Bastianina Canu and Paola Orlandi and Teresa Di Desidero and Romano Danesi and Guido Bocci},
  journal={Investigational New Drugs},
  year={2011},
  volume={30},
  pages={1725-1730}
}
Metronomic chemotherapy—the low-dose, long term and frequently administered chemotherapy—has revealed in these years an important impact on the stabilization of cancer disease for its known antiangiogenic effects, prolonged clinical benefits and the improved quality of life of several cancer patients, without any high grade toxicity [1–3]. Both the low cost and the oral administration of the drugs are key characteristics of this schedule and may offer important social advantages [4… CONTINUE READING